Quantcast
Last updated on April 17, 2014 at 7:46 EDT

DrugRisk Alerts Former Patients that Court Postpones Merck’s NuvaRing Lawsuit Trials

December 6, 2012

The Drug Risk Resource Center is the Web´s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

Miami, FL (PRWEB) December 05, 2012

The DrugRisk Resource Center, a patient awareness group, is alerting women who suffered side effects after using the contraceptive NuvaRing that a judge recently postponed the start of important bellweather trials.

U.S. District Judge Rodney Sippel, who will preside over NuvaRing lawsuits filed by patients around the country, recently issued an order moving trial dates from May 6 to July 8, 2013.*

The change comes as the 2012 Statistical Analysis from the Judicial Panel on MultiDistrict Litigation reports as many as 1,028 NuvaRing lawsuits have been moved to Judge Sippel´s federal court in Missouri.** The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.

Anyone who suffered blood clots, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible. The later trial dates will give those who have yet to learn their options after an injury more time to do so.

Experts have related vaginal rings like NuvaRing to higher blood clot risks than with traditional birth control pills.

The British Medical Journal published a Danish study on May 10, 2012 linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives. On June 14, 2012, the New England Journal of Medicine also published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.

So far, the FDA has received more than 1,000 reports of blood clot injury or death in patients using NuvaRing, according to an article in CBS News San Diego on September 21, 2012.

The DrugRisk Resource Center urges anyone affected by blood clots, stroke, DVT or pulmonary embolism after using NuvaRing to learn their treatment options and legal rights.

Due to the specialized nature of federal MDL drug injury cases, DrugRisk only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Order # 1423, Novenber 20, 2012, Case: 4:08-md-01964-RWS

**http://www.jpml.uscourts.gov/sites/jpml/files/JPML_Statistical_Analysis_of_Multidistrict_Litigation-2012.pdf

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebnuvaring-blood/clot-risks-lawsuit/prweb10202783.htm


Source: prweb